Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
A first consideration done was that, according to recent meetings which focused on the ESC/EACTS 2010 myocardial revascularization guidelines, the implementation rate of the guidelines in Europe is still rather low. Therefore national societies should increase their interaction with ESC in order to assess on an annual basis the achievements realized in terms of guidelines implementations. In addition proper patient consent should be encouraged and appropriate revascularization modalities should be discussed by the heart team. From that point of view the WG feels that it is extremely important to avoid confusion and misconception regarding which CAD patients should be discussed by the heart team. Therefore two algorithms were prepared during the meeting showing the pathway to follow in choosing the most appropriate intervention in CAD patients and when the patient needs to be discussed by the heart team. Those charts will be proposed for inclusion into the new ESC guidelines on stable angina.
The Survey promoted by the WG on the implementation of the myocardial revascularization guidelines and MDT approach in cardiovascular disease was discussed and is now ready to be published on the ESC web site.
In addition the WG position paper on “Management of anti-thrombotic therapy in patients with coronary artery disease undergoing CABG” was presented. The manuscript was carefully reviewed by all the nucleus members and will be further reviewed by the ESC antithrombotic therapy experts before the final submission.
In terms of educational purposes, the Nucleus members identified the following as two important areas where training is more needed and should be encouraged:
- mitral valve repair
- more use of arterial grafts for myocardial revascularization
Dedicated grants will be found mainly from industries to offer training periods in those fields to trainees.
Finally a decision was made about scheduling the next WG meeting in August 2012 during the ESC Congress.